NUVB
Nuvation Bio Inc.
NYSE · USHealthcareBiotechnology
$6.38+10.09%
Price as of Jul 20, 2026
NUVB ownership
Nuvation Bio Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
6/100
Buys (3m)
1
Sells (3m)
5
Net (3m)
-$1.7M
Insiders buyingFirst buy in 4 quarters
Insider trades by month Buys Sells
Jun
Oct
Nov
Dec
Apr
Jun
Context3-month price +13.3%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Sauvage Philippeofficer: Chief Financial Officer | Option | 39,999 | $2.17 |
| Jul 17, 2026 | Sauvage Philippeofficer: Chief Financial Officer | Option | 1 | $1.97 |
| Jun 24, 2026 | Sauvage Philippeofficer: Chief Financial Officer | Sell | 47,668 | $6.01 |
| Jun 24, 2026 | Markel Stacyofficer: CHIEF PEOPLE OFFICER | Option | 90,380 | $1.87 |
| Jun 24, 2026 | Markel Stacyofficer: CHIEF PEOPLE OFFICER | Option | 34,620 | $1.74 |
| Jun 24, 2026 | Markel Stacyofficer: CHIEF PEOPLE OFFICER | Sell | 125,000 | $6.03 |
| Jun 24, 2026 | Wentworth Kerryofficer: CHIEF REGULATORY OFFICER | Option | 63,000 | $2.93 |
| Jun 24, 2026 | Wentworth Kerryofficer: CHIEF REGULATORY OFFICER | Sell | 63,000 | $6.02 |
| Jun 24, 2026 | Sauvage Philippeofficer: Chief Financial Officer | Option | 47,668 | $2.17 |
| Jun 11, 2026 | Mashal Robertdirector | Buy | 25,000 | $4.73 |
| May 26, 2026 | FALBERG KATHRYN Edirector | Grant | 123,397 | $4.79 |
| May 26, 2026 | BLICKENSTAFF KIM Ddirector | Grant | 123,397 | $4.79 |
| May 26, 2026 | Bazemore Robert Bdirector | Grant | 123,397 | $4.79 |
| May 26, 2026 | Cui Xiangmindirector | Grant | 123,397 | $4.79 |
| May 26, 2026 | Cui Xiangmindirector | Grant | 76,923 | $5.91 |
| May 26, 2026 | Mashal Robertdirector | Grant | 123,397 | $4.79 |
| May 26, 2026 | VERNON W ANTHONYdirector | Grant | 123,397 | $4.79 |
| Apr 21, 2026 | Wentworth Kerryofficer: CHIEF REGULATORY OFFICER | Option | 36,750 | $2.93 |
| Apr 21, 2026 | Wentworth Kerryofficer: CHIEF REGULATORY OFFICER | Sell | 36,750 | $5.01 |
| Apr 21, 2026 | Liu Dongfangofficer: CHIEF MEDICAL OFFICER | Option | 50,000 | $1.94 |
| Apr 21, 2026 | Liu Dongfangofficer: CHIEF MEDICAL OFFICER | Sell | 50,000 | $5.02 |
| Apr 8, 2026 | Wentworth Kerryofficer: CHIEF REGULATORY OFFICER | Sell | 200,000 | $4.52 |
| Apr 8, 2026 | Wentworth Kerryofficer: CHIEF REGULATORY OFFICER | Option | 100,000 | $1.87 |
| Mar 3, 2026 | Makunje Mosesofficer: SEE REMARKS | Grant | 224,439 | $5.91 |
| Mar 3, 2026 | Liu Dongfangofficer: CHIEF MEDICAL OFFICER | Grant | 748,130 | $5.91 |
| Mar 3, 2026 | Hung Daviddirector, 10 percent owner, officer: PRESIDENT AND CEO | Grant | 1,995,012 | $5.91 |
| Mar 3, 2026 | Hanley David C.officer: CHIEF TECHNICAL OPERATIONS | Grant | 748,130 | $5.91 |
| Mar 3, 2026 | Hattersley Garyofficer: CHIEF SCIENTIFIC OFFICER | Grant | 748,130 | $5.91 |
| Mar 3, 2026 | Cui Xiangmindirector | Grant | 74,813 | $5.91 |
| Mar 3, 2026 | Markel Stacyofficer: CHIEF PEOPLE OFFICER | Grant | 748,130 | $5.91 |
Source: NUVB SEC Form 4 filings, latest Jul 17, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their NUVB positions over the last 6 months (SEC Form 13F).
Increased
167
New positions
97
Reduced
129
Sold out
73
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 52.0M | May 15, 2026 |
| FMR LLC | Increased | 51.4M | Feb 17, 2026 |
| DECHENG CAPITAL LLC | Unchanged | 26.0M | May 13, 2026 |
| DECHENG CAPITAL LLC | Unchanged | 26.0M | Feb 12, 2026 |
| BLACKROCK, INC. | Increased | 25.1M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 24.7M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 15.6M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 11.6M | May 15, 2026 |
| OMEGA FUND MANAGEMENT, LLC | Reduced | 8.1M | Feb 17, 2026 |
| OMEGA FUND MANAGEMENT, LLC | Unchanged | 8.1M | May 15, 2026 |
| LAURION CAPITAL MANAGEMENT LP | Reduced | 7.9M | Feb 17, 2026 |
| LAURION CAPITAL MANAGEMENT LP | Reduced | 7.8M | May 14, 2026 |
| STATE STREET CORP | Increased | 6.8M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 5.9M | May 15, 2026 |
| STATE STREET CORP | Reduced | 5.9M | Feb 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.